PPIs and Potassium-Competitive Acid Blockers (PCABs)

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/25

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 3:24 PM on 9/4/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

26 Terms

1
New cards

What is important about this drug’s metabolism?


Metabolized by both CYP2C19 and CYP3A4

  • Very variable between different patients


2
New cards

What is important about this drug’s metabolism?


Less susceptible to first-pass CYP2C19 metabolism

  • More bioavailable and predictable than omeprazole


3
New cards

What are important SARs about this drug?

  • Fluorination slows down oxidation metabolism by the CYPs

    • More stable and less variable


4
New cards

What is the SAR from the r-enantiomer?

Increases duration of action

Decreases interpatient variability

5
New cards

What is important about how this drug is formulated?


Uses dual delayed-release formulation to have prolonged action

6
New cards

What is the benefit of this drug compared to other PPIs?


Longer duration of action

  • can be taken before or after a meal

Dual action allows pain relief during evening and night


7
New cards

Based on this table, which drug will have the fastest onset of action?


Rabeprazole (High pKa 1)

8
New cards

What is the main benefit of this drug compared to the other PPIs?


Spontaneously decomposes to activate

  • little reliance on CYP2C19 metabolization


9
New cards

What is the SAR of this molecule?


Difluromethyl group decreases onset of action

3,4-dimethoxypyridine increases acid trapping

10
New cards

What is the benefit of this drug’s metabolites?


Less dependent on CYP metabolism

  • IV and PO used in hospitals


11
New cards

Which PPIs have high dependence on CYP2C19?

Omeprazole

Lansoprazole

Dexlansoprazole

12
New cards

What PPIs have low CYP2C19 dependence?

Pantoprazole

Rabeprazole

13
New cards

What PPIs have a fast onset?

Lansoprazole

Rabeprazole (Fastest)

14
New cards

Which PPIs have a slow onset?

Pantoprazole

15
New cards

What are the issues related to PPI use?

Poor absorption

Some drugs and minerals need the acidic environment

Decrease Microbiota survivability

16
New cards

What vitamins / nutrients do PPI impact absorption of?

Vitamin B12

Magnesium

Calcium

Iron

17
New cards

What are the 2 adverse effects of B12 deficiency

Neural and cognitive problems

18
New cards

What are the 2 adverse effects of magnesium deficiency?

Muscle and heart issues

19
New cards

What are the 2 adverse effects of calcium deficiency?

Increase fracture risk and decreased bone density

20
New cards

What is the adverse effect of iron deficiency?

Anemia

21
New cards

What infections are people who use PPIs for the first time or are elderly at risk of?

C. diff and CAP (Community-acquired pneumonia)

22
New cards

What kidney problems arise in people using PPIs?

Acute interstitial nephritis

CKD (Irreversible if untreated)

23
New cards

What happens if you take PPIs for a long period of time?

Overstimulation of parietal cells

  • Rebound acid secretion

    • Especially after stopping the drug


24
New cards

What type of drug is this?


Potassium-competitive acid blocker (PCAB)

25
New cards

How does this drug work?


Reversibly and competitively bind to H+/K+ ATPase

26
New cards

What are the 3 benefits of this drug?


Relief of symptoms independent of food intake

Less CYP metabolism

More effective at treating H.pylori infections